Loading clinical trials...
Loading clinical trials...
This single arm study will evaluate the efficacy, safety and tolerability of a new investigational protease inhibitor (PI) plus background antiretrovirals plus Fuzeon (90mg sc bid) in HIV-1 infected, ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hoffmann-La Roche
Collaborators
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT04142047 · HIV, HIV Infections
NCT06694805 · HIV Infections
NCT07428330 · Cervix Cancer, HIV Infections, and more
NCT05398185 · HIV Infections, Acquired Immune Deficiency Syndrome, and more
Phoenix, Arizona
Bakersfield, California
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions